title: Comment on "Dysregulated production of leukemia inhibitory factor in immune cells of relapsing remitting multiple sclerosis patients" by Levy et al. J. Neuroimmunol. 2015 Jan 15; 278C:85-89.
authors.affiliation: Tissue Typing Laboratory, Department of Transplantation Immunology, School of Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: Vanderlocht
authors.affiliation: Biomedical Research Institute and Transnationale Universiteit Limburg, School of Life Sciences, Hasselt University, 3590 Diepenbeek, Belgium. Electronic address: niels.hellings@uhasselt.be.
authors.forename: N
authors.initials: N
authors.lastname: Hellings
mesh_terms: D005260:Female; D006801:Humans; D053605:Leukemia Inhibitory Factor / Q000378:metabolism*; D007963:Leukocytes, Mononuclear / Q000378:metabolism*; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000276:immunology* / Q000473:pathology*
chemical_list: D053605:Leukemia Inhibitory Factor
keywords: Leukemia inhibitory receptor; Multiple sclerosis